Delivery across the blood-brain barrier of antisense directed against amyloid beta: Reversal of learning and memory deficits in mice overexpressing amyloid precursor protein
Wa. Banks et al., Delivery across the blood-brain barrier of antisense directed against amyloid beta: Reversal of learning and memory deficits in mice overexpressing amyloid precursor protein, J PHARM EXP, 297(3), 2001, pp. 1113-1121
Citations number
44
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Amyloid beta protein (A beta) may play a causal role in Alzheimer's disease
. Previous work has shown that the learning and memory deficits that develo
p with aging in SAMP8 mice, a strain that overproduces A beta, can be rever
sed with i.c.v. injections of an AP antisense phosphorothiolate oligonucleo
tide (Olg), Here, we showed that Olg radioactively labeled with P-32 (P-Olg
) was transported intact across the blood-brain barrier (BBB) of mice by a
saturable system, termed oligonucleotide transport system-1 (OTS-1). Multip
le-time regression analysis found a blood-to-brain unidirectional influx ra
te for P-Olg of 1.4 +/- 0.39 mul/g-min and capillary depletion showed that
P-Olg completely crossed the BBB to enter the parenchymal space of the brai
n. P-Olg was also shown to enter the cerebrospinal fluid. Transport was esp
ecially high into the hippocampus, with the percentage of the i.v. dose tak
en up by each gram of brain (0.865 +/- 0.115%) being about 1/100 of the i.c
.v. dose. An i.v. dose of Olg 100 times that of the effective i.c.v. dose r
eversed the learning and memory deficits of aged SAMP8 mice. These studies
show for the first time that phosphorothiolate oligonucleotides can be deli
vered to the brain in effective doses by intravenous administration.